232 related articles for article (PubMed ID: 9292882)
1. Prolonged treatment with haloperidol and clozapine in the rat: differential effects on spontaneous and theophylline-induced motor activity.
Ogren SO; Ferré S; Schwarcz R; Fuxe K
Neurosci Lett; 1997 Aug; 232(1):21-4. PubMed ID: 9292882
[TBL] [Abstract][Full Text] [Related]
2. Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, but not serotonin 5-Ht4 or 5-Ht6 receptors following antipsychotic administration.
Ward RP; Dorsa DM
Neuroscience; 1999 Mar; 89(3):927-38. PubMed ID: 10199625
[TBL] [Abstract][Full Text] [Related]
3. Effect of subtype-selective adenosine receptor antagonists on basal or haloperidol-regulated striatal function: studies of exploratory locomotion and c-Fos immunoreactivity in outbred and A(2A)R KO mice.
Pardo M; López-Cruz L; Valverde O; Ledent C; Baqi Y; Müller CE; Salamone JD; Correa M
Behav Brain Res; 2013 Jun; 247():217-26. PubMed ID: 23557694
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment.
Tarazi FI; Florijn WJ; Creese I
Neuroscience; 1997 Jun; 78(4):985-96. PubMed ID: 9174067
[TBL] [Abstract][Full Text] [Related]
5. Subchronic administration of clozapine, but not haloperidol or metoclopramide, decreases dopamine D2 receptor messenger RNA levels in the nucleus accumbens and caudate-putamen in rats.
See RE; Lynch AM; Sorg BA
Neuroscience; 1996 May; 72(1):99-104. PubMed ID: 8730709
[TBL] [Abstract][Full Text] [Related]
6. Chronic haloperidol treatment leads to an increase in the intramembrane interaction between adenosine A2 and dopamine D2 receptors in the neostriatum.
Ferré S; Schwarcz R; Li XM; Snaprud P; Ogren SO; Fuxe K
Psychopharmacology (Berl); 1994 Nov; 116(3):279-84. PubMed ID: 7892417
[TBL] [Abstract][Full Text] [Related]
7. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Kumagai T; Nakazato A; Nagamine M; Yamaguchi K; Tomisawa K
Br J Pharmacol; 1997 Jun; 121(3):515-25. PubMed ID: 9179395
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of clozapine and haloperidol on dopamine receptor mRNA expression in rat striatum and cortex.
Damask SP; Bovenkerk KA; de la Pena G; Hoversten KM; Peters DB; Valentine AM; Meador-Woodruff JH
Brain Res Mol Brain Res; 1996 Sep; 41(1-2):241-9. PubMed ID: 8883957
[TBL] [Abstract][Full Text] [Related]
9. Effects of serotonergic agents on the up-regulation of dopamine D2 receptors induced by haloperidol in rat striatum.
Ishikane T; Kusumi I; Matsubara R; Matsubara S; Koyama T
Eur J Pharmacol; 1997 Feb; 321(2):163-9. PubMed ID: 9063684
[TBL] [Abstract][Full Text] [Related]
10. Why does clozapine stimulate the motor activity of reserpine-pretreated rats when combined with a dopamine D1 receptor agonist?
Jackson DM; Mohell N; Bengtsson A; Malmberg A
Eur J Pharmacol; 1995 Aug; 282(1-3):137-44. PubMed ID: 7498268
[TBL] [Abstract][Full Text] [Related]
11. Involvement of adenosine A2A receptors in the induction of c-fos expression by clozapine and haloperidol.
Pinna A; Wardas J; Cozzolino A; Morelli M
Neuropsychopharmacology; 1999 Jan; 20(1):44-51. PubMed ID: 9885784
[TBL] [Abstract][Full Text] [Related]
12. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
[TBL] [Abstract][Full Text] [Related]
13. Neuroleptics up-regulate adenosine A2a receptors in rat striatum: implications for the mechanism and the treatment of tardive dyskinesia.
Parsons B; Togasaki DM; Kassir S; Przedborski S
J Neurochem; 1995 Nov; 65(5):2057-64. PubMed ID: 7595490
[TBL] [Abstract][Full Text] [Related]
14. Effects of chronic treatment with typical and atypical antipsychotic drugs on the rat striatum.
Lee H; Tarazi FI; Chakos M; Wu H; Redmond M; Alvir JM; Kinon BJ; Bilder R; Creese I; Lieberman JA
Life Sci; 1999; 64(18):1595-602. PubMed ID: 10328519
[TBL] [Abstract][Full Text] [Related]
15. Long-term treatment with haloperidol or clozapine does not affect dopamine D4 receptors in rat frontal cortex.
Kusumi I; Ishikane T; Matsubara S; Koyama T
J Neural Transm Gen Sect; 1995; 101(1-3):231-5. PubMed ID: 8695053
[TBL] [Abstract][Full Text] [Related]
16. Clozapine, haloperidol, and the D4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin release.
Broderick PA; Piercey MF
J Neural Transm (Vienna); 1998; 105(6-7):749-67. PubMed ID: 9826116
[TBL] [Abstract][Full Text] [Related]
17. Effects of ritanserin on haloperidol-induced dopamine (D2) receptor up-regulation in the rat.
Szczepanik AM; Wilmot CA
Neurosci Lett; 1997 Aug; 231(2):91-4. PubMed ID: 9291148
[TBL] [Abstract][Full Text] [Related]
18. Regionally specific effects of haloperidol and clozapine on dopamine reuptake in the striatum.
Rothblat DS; Schneider JS
Neurosci Lett; 1997 Jun; 228(2):119-22. PubMed ID: 9209113
[TBL] [Abstract][Full Text] [Related]
19. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
Florijn WJ; Tarazi FI; Creese I
J Pharmacol Exp Ther; 1997 Feb; 280(2):561-9. PubMed ID: 9023264
[TBL] [Abstract][Full Text] [Related]
20. Clozapine antagonizes the induction of striatal Fos expression by typical neuroleptics.
Wirtshafter D
Eur J Pharmacol; 1998 Oct; 358(3):R1-3. PubMed ID: 9822897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]